FDG PET/CT and diffusion-weighted imaging of head and neck squamous cell carcinoma: Comparison of prognostic significance between primary tumor standardized uptake value and apparent diffusion coefficient

Clinical Nuclear Medicine

Volumn 37, Issue 5, 2012, Pages 475-480

  Nakajo, Masatoyo ^a,b   Nakajo, Masayuki ^a   Kajiya, Yoriko ^b   Tani, Atsushi ^b   Kamiyama, Takuro ^c   Yonekura, Ryuji ^c   Fukukura, Yoshihiko ^a   Matsuzaki, Tsutomu ^c   Nishimoto, Kengo ^c   Nomoto, Mitsuharu ^c   Koriyama, Chihaya ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

^b Nanpuh Hospital   (Japan)

^c NATIONAL HOSPITAL ORGANIZATION KAGOSHIMA MEDICAL CENTER   (Japan)

Author keywords

ADC; FDG; head and neck cancer; prognosis; SUV

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; DIFFUSION COEFFICIENT; DIFFUSION WEIGHTED IMAGING; DISEASE FREE SURVIVAL; DRUG UPTAKE; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HEAD AND NECK CARCINOMA; HUMAN; IMAGE ANALYSIS; LYMPH NODE METASTASIS; MALE; MULTIDETECTOR COMPUTED TOMOGRAPHY; POSITRON EMISSION TOMOGRAPHY; PREDICTIVE VALUE; QUANTITATIVE ANALYSIS; RECURRENT CANCER; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SQUAMOUS CELL CARCINOMA; STANDARDIZATION; THREE DIMENSIONAL IMAGING;

AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; DIFFUSION; DIFFUSION MAGNETIC RESONANCE IMAGING; DISEASE-FREE SURVIVAL; FEMALE; FLUORODEOXYGLUCOSE F18; HEAD AND NECK NEOPLASMS; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY; PROGNOSIS; PROPORTIONAL HAZARDS MODELS;

EID: 84859631310     PISSN: 03639762     EISSN: 15360229     Source Type: Journal    
DOI: 10.1097/RLU.0b013e318248524a     Document Type: Article

References (30)

1. Dimery IW, Hong WK. Overview of combined modality therapies for head and neck cancer. J Natl Cancer Inst. 1993;85:95-111. (Pubitemid 23028714)
2. Chiesa F, Mauri S, Tradati N, et al. Surfing prognostic factors in head and neck cancer at the millennium. Oral Oncol. 1999;35:590-596. (Pubitemid 29506986)
3. Rigo P, Paulus P, Kaschten BJ, et al. Oncological applications of positron emission tomography with fluorine-18 fluorodeoxyglucose. Eur J Nucl Med. 1996;23:1641-1674.
4. Minn H, Lapela M, Klemi PJ, et al. Prediction of survival with fluorine-18- fluoro-deoxyglucose and PET in head and neck cancer. J Nucl Med. 1997; 38:1907-1911. (Pubitemid 28030920)
5. Roh JL, Pae KH, Choi SH, et al. 2-[18F]-Fluoro-2-deoxy-D-glucose positron emission tomography as guidance for primary treatment in patients with advanced-stage resectable squamous cell carcinoma of the larynx and hypopharynx. Eur J Surg Oncol. 2007;33:790-795. (Pubitemid 47029672)
6. Schwartz DL, Rajendran J, Yueh B, et al. FDG-PET prediction of head and neck squamous cell cancer outcomes. Arch Otolaryngol Head Neck Surg. 2004;130:1361-1367. (Pubitemid 39603296)
7. Machtay M, Natwa M, Andrel J, et al. Pretreatment FDG-PET standardized uptake value as a prognostic factor for outcome in head and neck cancer. Head Neck. 2009;31:195-201.
8. Halfpenny W, Hain SF, Biassoni L, et al. FDG-PET. A possible prognostic factor in head and neck cancer. Br J Cancer. 2002;86:512-516. (Pubitemid 34185084)
9. Koh DM, Takahara T, Imai Y, et al. Practical aspects of assessing tumors using clinical diffusion-weighted imaging in the body. Magn Reson Med Sci. 2007;6:211-224.
10. Kim S, Loevner L, Quon H, et al. Diffusion-weighted magnetic resonance imaging for predicting and detecting early response to chemoradiation therapy of squamous cell carcinomas of the head and neck. Clin Cancer Res. 2009;15:986-994.
11. Kato H, Kanematsu M, Tanaka O, et al. Head and neck squamous cell carcinoma: usefulness of diffusion-weighted MR imaging in the prediction of a neoadjuvant therapeutic effect. Eur Radiol. 2009;19:103-109.
12. Hatakenaka M, Nakamura K, Yabuuchi H, et al. Pretreatment apparent diffusion coefficient of the primary lesion correlates with local failure in head-and-neck cancer treated with chemoradiotherapy or radiotherapy. Int J Radiat Oncol Biol Phys. 2011;81:339-345.
13. Haerle SK, Huber GF, Hany TF, et al. Is there a correlation between 18F-FDG-PET standardized uptake value, T-classification, histological grading and the anatomic subsites in newly diagnosed squamous cell carcinoma of the head and neck? Eur Arch Otorhinolaryngol. 2010;267:1635-1640.
14. Suzuki K, Nishioka T, Homma A, et al. Value of fluorodeoxyglucose positron emission tomography before radiotherapy for head and neck cancer: does the standardized uptake value predict treatment outcome? Jpn J Radiol. 2009; 27:237-242.
15. Torizuka T, Tanizaki Y, Kanno T, et al. Prognostic value of 18F-FDG PET in patients with head and neck squamous cell cancer. Am J Roentgenol. 2009;192:W156-W160.
16. Inohara H, Enomoto K, Tomiyama Y, et al. Impact of FDG-PET on prediction of clinical outcome after concurrent chemoradiotherapy in hypopharyngeal carcinoma. Mol Imaging Biol. 2010;12:89-97.
17. Sinha S, Lucas-Quesada FA, Sinha U, et al. In vivo diffusion-weighted MRI of the breast: potential for lesion characterization. J Magn Reson Imaging. 2002;15:693-704. (Pubitemid 34606504)
18. Wang J, Takashima S, Takayama F, et al. Head and neck lesions: characterization with diffusion-weighted echo-planar MR imaging. Radiology. 2001; 220:621-630. (Pubitemid 32799967)
19. Abdel Razek AA, Gaballa G, Elhawarey G, et al. Characterization of pediatric head and neck masses with diffusion-weighted MR imaging. Eur Radiol. 2009;19:201-208.
20. Srinivasan A, Dvorak R, Perni K, et al. Differentiation of benign and malignant pathology in the head and neck using 3T apparent diffusion coefficient values: early experience. Am J Neuroradiol. 2008;29:40-44.
21. Fong D, Bhatia KS, Yeung D, et al. Diagnostic accuracy of diffusion-weighted MR imaging for nasopharyngeal carcinoma, head and neck lymphoma and squamous cell carcinoma at the primary site. Oral Oncol. 2010;46:603-606.
22. King AD, Mo FK, Yu KH, et al. Squamous cell carcinoma of the head and neck: diffusion-weighted MR imaging for prediction and monitoring of treatment response. Eur Radiol. 2010;20:2213-2220.
23. Srinivasan A, Dvorak R, Mukherji SK. Initial experience of 3-Tesla apparent diffusion coefficient values in characterizing squamous cell carcinoma of the head and neck. Acta Radiol. 2008;49:1079-1084.
24. Friedrich KM, Matzek W, Gentzsch S, et al. Diffusion-weighted magnetic resonance imaging of head and neck squamous cell carcinomas. Eur J Radiol. 2008;68:493-498.
25. 18F-FDG uptake with apparent diffusion coefficient ratio measured on standard and high b value diffusion MRI in head and neck cancer. J Nucl Med. 2011;52:1056-1062.
26. Abdel Razek AA, Soliman NY, Elkhamary S, et al. Role of diffusion-weighted MR imaging in cervical lymphadenopathy. Eur Radiol. 2006;16: 1468-1477. (Pubitemid 43871818)
27. Sumi M, Sakihama N, Sumi T, et al. Discrimination of metastatic cervical lymph nodes with diffusion-weighted MR imaging in patients with head and neck cancer. Am J Neuroradiol. 2003;24:1627-1634. (Pubitemid 37151732)
28. Minn H, Clavo AC, Grénman R, et al. In vitro comparison of cell proliferation kinetics and uptake of tritiated fluorodeoxyglucose and L-methionine in squamous-cell carcinoma of the head and neck. J Nucl Med. 1995;36:252-258.
29. Nakajo M, Kajiya Y, Kaneko T, et al. FDG PET/CT and diffusion-weighted imaging for breast cancer: prognostic values of maximum standardized uptake values and apparent diffusion coefficient values of the primary lesion. Eur J Nucl Med Mol Imaging. 2010;37:2011-2020.
30. Taguchi T, Tsukuda M, Mikami Y, et al. Treatment results and prognostic factors for advanced squamous cell carcinoma of the head and neck treated with concurrent chemoradiotherapy. Auris Nasus Larynx. 2009;36:199-204.